Kalra, Maitri
Tong, Yan
Jones, David R.
Walsh, Tom
Danso, Michael A.
Ma, Cynthia X.
Silverman, Paula
King, Mary-Claire http://orcid.org/0000-0001-9426-1743
Badve, Sunil S.
Perkins, Susan M.
Miller, Kathy D. http://orcid.org/0000-0002-7125-883X
Funding for this research was provided by:
Breast Cancer Relief Foundation
Susan G. Komen
Article History
Received: 4 September 2020
Accepted: 26 February 2021
First Online: 22 March 2021
Competing interests
: Pfizer initially provided rucaparib and partial financial support for this trial but was not involved in the study design. During the conduct of this trial, Clovis Oncology acquired rucaparib and assumed support for this trial. Neither Pfizer nor Clovis Oncology participated in data collection or analysis. The authors declare no other competing interests.